Ruye Ma
Shanghai, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
CAPN1 is a novel biomaker of patients with AML based on comprehensive analysis.
Journal: Biotechnology & genetic engineering reviews
Published: April 28, 2023
DCZ0014, a novel compound in the therapy of diffuse large B-cell lymphoma via the B cell receptor signaling pathway.
Journal: Neoplasia (New York, N.Y.)
Published: June 14, 2021
Quercetin inhibits the proliferation of multiple myeloma cells by upregulating PTPRR expression.
Journal: Acta biochimica et biophysica Sinica
Published: April 10, 2021
Anti-DLBCL efficacy of DCZ0825 in vitro and in vivo: involvement of the PI3K‒AKT‒mTOR/JNK pathway.
Journal: Acta biochimica et biophysica Sinica
Published: November 03, 2020
Resveratrol induces AMPK and mTOR signaling inhibition-mediated autophagy and apoptosis in multiple myeloma cells.
Journal: Acta biochimica et biophysica Sinica
Published: October 12, 2020
Iron overload adversely effects bone marrow haematogenesis via SIRT-SOD2-mROS in a process ameliorated by curcumin.
Journal: Cellular & molecular biology letters
Published: August 06, 2020
Inhibition of autophagy enhances the antitumour activity of tigecycline in multiple myeloma.
Journal: Journal of cellular and molecular medicine
Published: April 17, 2018
Benzene metabolite hydroquinone induces apoptosis of bone marrow mononuclear cells through inhibition of β-catenin signaling.
Journal: Toxicology in vitro : an international journal published in association with BIBRA
Published: March 17, 2017
Matrine induces Akt/mTOR signalling inhibition-mediated autophagy and apoptosis in acute myeloid leukaemia cells.
Journal: Journal of cellular and molecular medicine
Published: July 16, 2016
Showing 1-9 of 9
Last Updated: 09/26/2026